Page 119 - 202001

hort analysis[J]. Clin Ther，2010，32（4）：637-648. therapies in febrile neutropenic patients with hematologi-
[ 3 ] CORNELY OA，GACHOT B，AKAN H，et al. Epidemi- cal disorders：a randomized controlled trial[J]. Eur J Hae-
ology and outcome of fungemia in a cancer cohort of the matol，2016，96（6）：602-609.
infectious diseases group（IDG）of the european organiza- [14] WALSH TJ，TEPPLER H，DONOWITZ GR，et al. Ca-
tion for research and treatment of cancer[J]. Clin Infect spofungin versus liposomal amphotericin B for empirical
Dis，2015，61（3）：324-331. antifungal therapy in patients with persistent fever and
[ 4 ] PAPPAS PG，KAUFFMAN CA，ANDES DR，et al. Clin- neutropenia[J]. N Engl J Med，2004，351（14）：1391-
ical practice guideline for the management of candidiasis： 1402.
2016 update by the infectious diseases society of America [15] TAPLITZ RA，KENNEDY EB，BOW EJ，et al. Antimi-
[J]. Clin Infect Dis，2016，62（4）：e1-50. crobial prophylaxis for adult patients with cancer-related
[ 5 ] 魏晓晨，朱立勤，王春革.抗真菌药物预防肝移植术后侵 immunosuppression：ASCO and IDSA clinical practice
袭性真菌感染的疗效与安全性的 Meta 分析[J].中国药 guideline update[J]. J Clin Oncol，2018，36（30）：3043-
房，2014，25（24）：2238-2241. 3054.
[ 6 ] HUSAIN S，TOLLEMAR J，DOMINGUEZ EA，et al. Ch- [16] KUBIAK DW，BRYAR JM，MCDONNELL AM，et al.
anges in the spectrum and risk factors for invasive candidi- Evaluation of caspofungin or micafungin as empiric anti-
asis in liver transplant recipients：prospective，multi- fungal therapy in adult patients with persistent febrile neu-
center，case-controlled study[J]. Transplantation，2003，75 tropenia：a retrospective，observational，sequential co-
（12）：2023-2029. hort analysis[J]. Clinical Therapeutics，2010，4（32）：637-
[7] TOMBLYN M，CHILLER T，EINSELE H，et al. Guide- 648.
lines for preventing infectious complications among hema- [17] WINGARD JR，CARTER SL，WALSH TJ，et al. Ran-
topoietic cell transplantation recipients：a global perspec- domized，double-blind trial of fluconazole versus voricon-
tive[J]. Biol Blood Marrow Transplant，2009，15（10）： azole for prevention of invasive fungal infection after allo-
1143-1238. geneic hematopoietic cell transplantation[J]. Blood，2010，
[ 8 ] WINSTON DJ，LIMAYE AP，PELLETIER S，et al. Ran- 116（24）：5111-5118.
domized，double-blind trial of anidulafungin versus fluco- [18] PAPPAS PG，ALEXANDER BD，ANDES DR，et al. In-
nazole for prophylaxis of invasive fungal infections in vasive fungal infections among organ transplant recipi-
high-risk liver transplant recipients[J]. Am J Transplant， ents：results of the transplant-associated infection surveil-
2014，14（12）：2758-2764. lance network[J]. Clin Infect Dis，2010，50（8）：1101-
[ 9 ] KUSE ER，CHETCHOTISDKD P，DA CUNHA CA，et al. 1011.
Micafungin versus liposomal amphotericin B for candidae- [19] WANG J，ZHAN P，ZHOU R，et al. Prophylaxis with
mia and invasive candidosis：a phase Ⅲ randomized dou- itraconazole is more effective than prophylaxis with fluco-
ble-blind trial[J]. Lancet，2007，369（9572）：1519-1527. nazole in neutropenic patients with hematological malig-
[10] SALIBA F，PASCHER A，COINTAULT O，et al. Ran- nancies：a meta-analysis of randomized-controlled trials
domized trial of micafungin for the prevention of invasive [J]. Med Oncol，2010，27（4）：1082-1088.
fungal infection in high-risk liver transplant cecipients[J]. [20] ZIAKAS PD，KOURBTI IS，VOULGARELIS M，et al.
Clin Infect Dis，2015，60（7）：997-1006. Effectiveness of systemic antifungal prophylaxis in pa-
[11] VAN BURIK JA，RATANATHARATHOM V，STEPAN tients with neutropenia after chemotherapy：a meta-analy-
DE，et al. Micafungin versus fluconazole for prophylaxis sis of randomized controlled trials[J]. Clin Ther，2010，32
against invasive fungal infections during neutropenia in （14）：2316-2336.
patients undergoing hematopoietic stem cell transplanta- [21] VEKEMAN F，WEISS L，ARAM J，et al. Retrospective
tion[J]. Clin Infect Dis，2004，39（10）：1407-1416. cohort study comparing the risk of severe hepatotoxicity
[12] HANSON KE，PFEIFFER CD，LEASE ED，et al. β-D- in hospitalized patients treated with echinocandins forinva-
glucan surveillance with preemptive anidulafungin for in- sive candidiasis in the presence of confounding by indica-
vasive candidiasis in intensive care unit patients：a ran- tion[J]. BMC Infect Dis，2018，18（1）：438.
domized pilot study[J]. PLoS one，2012，7（8）：e42282. （收稿日期：2019-08-16 修回日期：2019-10-08）
[13] OYAKE T，KOWATA S，MURAI K，et al. Comparison （编辑：刘明伟）
of micafungin and voriconazole as empirical antifungal

中国药房 2020年第31卷第1期 China Pharmacy 2020 Vol. 31 No. 1 ·109 ·